Mission Bio, a US-based precision medicine and genomics spinout from University of California, San Francisco (UCSF), closed a $10m series A round yesterday backed by the Stanford University-affiliated Stanford-Start X fund.

The round was led by venture capital firm Mayfield Fund, with contributions from angel investment vehicles Keiretsu Forum, Tech Coast Angels and Life Science Angels.

Mission Bio has created a genomics-based analytics platform called Tapestri that has the potential to process as many as 10,000 cells while distinguishing each…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?